Gynuity Health Projects

Resources

Resources by Language

Language Selected: español (see all languages)

Misoprostol for Incomplete Abortion and Miscarriage

PAC in Action Newsletter: Special Issue on Misoprostol PAC Context

FAQs on Fatal Infection and Medical Abortion - Technical Version

FAQs on Fatal Infection and Medical Abortion - Summary

Policy and Advocacy Activities Brief

Medical Abortion Program Brief

Materials Development Activities Brief

Misoprostol and Teratogenicity: Reviewing the Evidence

Research

Postpartum Hemorrhage: A Challenge for Safe Motherhood

Infectious Disease Program Brief

Training and Education Activities Brief

Technical Assistance Activities Brief

Fever after treatment of postpartum hemorrhage

Preeclampsia Program Brief

Pregnancy Failure and Miscarriage Program Brief

Social Science Research Activities Brief

Blood Loss After Vaginal Delivery

Misoprostol for Prevention of Postpartum Hemorrhage

Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru

map of misoprostol approval

Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan

Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials

Guidebook on Misoprostol for Treatment of Incomplete Abortion

Annotated Bibliography - Mifepristone Medical Abortion

Medical Abortion Guidebook 2nd-ed

Abortion With Self-Administered Misoprostol: A Guide For Women

Reference List - Misoprostol for Treatment of Postpartum Hemorrhage

Misoprostol for Treatment of Postpartum Hemorrhage

Postpartum Hemorrhage: moving from research to reality

Misoprostol for Treatment of Incomplete Abortion in Guatemala

Institutional brochure-sp

Map of Mifepristone Approval

Misoprostol for Treatment of Incomplete Abortion: A Training guide

Misoprostol for Early Abortion

Mife plus miso or miso-alone for treatment of intrauterine fetal death 12-24 weeks’ LMP-sp

FAQ on Misoprostol Detection in Blood

Mife plus miso or miso-alone for abortion induction in pregnancies 12-24 weeks’ LMP-sp

List of Mifepristone Approval

WHO MODEL LIST OF ESSENTIAL MEDICINES UPDATED TO INCLUDE MISOPROSTOL FOR PPH

Postpartum Hemorrhage Program Brief